Mamlins, EduardsScharbert, LaraCardinale, JensKrotov, MariaWinter, ErikRathke, HendrikStrodel, BirgitAnkrah, Alfred OSathekge, Mike MachabaHaberkorn, UweKratochwil, ClemensGiesel, Frederik L.2024-05-102024-05-102024-02Mamlins, E., Scharbert, L., Cardinale, J. et al. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular Imaging and Biology 26, 81–89 (2024). https://doi.org/10.1007/s11307-023-01881-y.1536-1632 (print)1860-2002 (online)10.1007/s11307-023-01881-yhttp://hdl.handle.net/2263/95872DATA AVAILABILITY : The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.Please read abstract in the article.en© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.PSMA-GCK01Technetium-99 mSingle-photon emission computed tomography (SPECT)TheranosticsProstate cancerProstate-specific membrane antigen (PSMA)SDG-03: Good health and well-beingArticle